These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3205168

  • 1. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D, Etienne-Decerf J, Schrooyen M, Sand G, Hoyoux P, Mahieu P, Winand R.
    Metab Pediatr Syst Ophthalmol (1985); 1988; 11(3):133-40. PubMed ID: 3205168
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy.
    Glinoer D, Etienne-Decerf J, Schrooyen M, Sand G, Hoyoux P, Mahieu P, Winand R.
    Acta Endocrinol (Copenh); 1986 Jan; 111(1):30-8. PubMed ID: 2868602
    [Abstract] [Full Text] [Related]

  • 3. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D, Schrooyen M.
    Horm Res; 1987 Jan; 26(1-4):184-9. PubMed ID: 3596467
    [Abstract] [Full Text] [Related]

  • 4. Urinary glycosaminoglycans in Graves' ophthalmopathy.
    Kahaly G, Schuler M, Sewell AC, Bernhard G, Beyer J, Krause U.
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):35-44. PubMed ID: 2401097
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma exchange therapy for severe Graves' ophthalmopathy.
    Glinoer D, Schrooyen M, Winand R.
    Dev Ophthalmol; 1989 Jul; 20():91-3. PubMed ID: 2591631
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement.
    Yamamoto K, Saito K, Takai T, Yoshida S.
    Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L, Lundell G, Tørring O, Wallin G, Ljunggren JG, Blomgren H, Taube A.
    N Engl J Med; 1992 Jun 25; 326(26):1733-8. PubMed ID: 1489388
    [Abstract] [Full Text] [Related]

  • 18. Plasma exchange in endocrine ophthalmopathy.
    Berlin G, Hjelm H, Liedén G, Tegler L.
    J Clin Apher; 1990 Jun 25; 5(4):192-6. PubMed ID: 2228998
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.